Baxter (BAX) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

Baxter Revenue Highlights

Latest Revenue (Y)

$352.00M

Latest Revenue (Q)

$2.83B

Main Segment (Y)

Medical Products And Therapies

Main Geography (Y)

UNITED STATES

Baxter Revenue by Period

Baxter Revenue by Year

Date	Revenue	Change
2025-12-31	$352.00M	-96.69%
2024-12-31	$10.64B	2.66%
2023-12-31	$10.36B	3.01%
2022-12-31	$10.06B	-17.20%
2021-12-31	$12.15B	4.05%
2020-12-31	$11.67B	2.74%
2019-12-31	$11.36B	2.37%
2018-12-31	$11.10B	4.87%
2017-12-31	$10.58B	4.14%
2016-12-31	$10.16B	1.96%
2015-12-31	$9.97B	-7.01%
2014-12-31	$10.72B	13.87%
2013-12-31	$9.41B	-32.46%
2012-12-31	$13.94B	0.31%
2011-12-31	$13.89B	8.18%
2010-12-31	$12.84B	2.24%
2009-12-31	$12.56B	1.73%
2008-12-31	$12.35B	9.63%
2007-12-31	$11.26B	8.53%
2006-12-31	$10.38B	5.37%
2005-12-31	$9.85B	3.58%
2004-12-31	$9.51B	6.79%
2003-12-31	$8.90B	9.94%
2002-12-31	$8.10B	10.10%
2001-12-31	$7.36B	9.84%
2000-12-31	$6.70B	4.97%
1999-12-31	$6.38B	11.81%
1998-12-31	$5.71B	8.50%
1997-12-31	$5.26B	-3.29%
1996-12-31	$5.44B	7.73%
1995-12-31	$5.05B	-45.86%
1994-12-31	$9.32B	-

Baxter generated $352.00M in revenue during NA 2025, up -96.69% compared to the previous quarter, and up 3.02% compared to the same period a year ago.

Baxter Revenue by Quarter

Date	Revenue	Change
2025-09-30	$2.83B	0.89%
2025-06-30	$2.81B	7.05%
2025-03-31	$2.63B	-4.65%
2024-12-31	$2.75B	2.00%
2024-09-30	$2.70B	0.19%
2024-06-30	$2.69B	8.19%
2024-03-31	$2.49B	-35.91%
2023-12-31	$3.88B	49.48%
2023-09-30	$2.60B	-29.89%
2023-06-30	$3.71B	5.52%
2023-03-31	$3.51B	-9.62%
2022-12-31	$3.89B	7.70%
2022-09-30	$3.61B	0.42%
2022-06-30	$3.59B	-3.05%
2022-03-31	$3.71B	5.49%
2021-12-31	$3.51B	8.93%
2021-09-30	$3.23B	4.13%
2021-06-30	$3.10B	5.16%
2021-03-31	$2.95B	-7.39%
2020-12-31	$3.18B	7.03%
2020-09-30	$2.97B	9.35%
2020-06-30	$2.72B	-3.00%
2020-03-31	$2.80B	-7.80%
2019-12-31	$3.04B	6.59%
2019-09-30	$2.85B	0.60%
2019-06-30	$2.83B	7.43%
2019-03-31	$2.64B	-7.15%
2018-12-31	$2.84B	2.90%
2018-09-30	$2.76B	-2.85%
2018-06-30	$2.84B	6.16%
2018-03-31	$2.68B	-3.50%
2017-12-31	$2.77B	2.48%
2017-09-30	$2.71B	3.92%
2017-06-30	$2.60B	5.25%
2017-03-31	$2.48B	-6.43%
2016-12-31	$2.65B	3.40%
2016-09-30	$2.56B	-1.04%
2016-06-30	$2.58B	8.84%
2016-03-31	$2.38B	-8.76%
2015-12-31	$2.60B	4.66%
2015-09-30	$2.49B	-36.12%
2015-06-30	$3.89B	3.43%
2015-03-31	$3.76B	-15.83%
2014-12-31	$4.47B	6.55%
2014-09-30	$4.20B	-1.57%
2014-06-30	$4.26B	7.92%
2014-03-31	$3.95B	-9.55%
2013-12-31	$4.37B	15.74%
2013-09-30	$3.77B	2.86%
2013-06-30	$3.67B	6.41%
2013-03-31	$3.45B	-8.13%
2012-12-31	$3.75B	7.94%
2012-09-30	$3.48B	-2.66%
2012-06-30	$3.57B	5.43%
2012-03-31	$3.39B	-5.73%
2011-12-31	$3.59B	3.31%
2011-09-30	$3.48B	-1.61%
2011-06-30	$3.54B	7.67%
2011-03-31	$3.28B	-6.12%
2010-12-31	$3.50B	8.50%
2010-09-30	$3.22B	0.94%
2010-06-30	$3.19B	9.12%
2010-03-31	$2.93B	-15.65%
2009-12-31	$3.47B	10.33%
2009-09-30	$3.15B	0.70%
2009-06-30	$3.12B	10.59%
2009-03-31	$2.82B	-9.81%
2008-12-31	$3.13B	-0.63%
2008-09-30	$3.15B	-1.19%
2008-06-30	$3.19B	10.84%
2008-03-31	$2.88B	-

Baxter generated $2.83B in revenue during Q3 2025, up 0.89% compared to the previous quarter, and up 105.23% compared to the same period a year ago.

Baxter Revenue Breakdown

Baxter Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Medical Products And Therapies	$5.30B	$5.21B	$1.05B	-	-
Healthcare Systems and Technologies	$3.07B	$2.95B	$1.21B	-	-
Pharmaceuticals	$2.49B	$2.41B	$2.25B	-	-
Kidney Care	-	-	$770.00M	-	-
Hillrom	-	-	-	$2.94B	$212.00M

Baxter's latest annual revenue breakdown by segment (product or service), as of Dec 25: Medical Products And Therapies (48.78%), Healthcare Systems and Technologies (28.27%), and Pharmaceuticals (22.95%).

Quarterly Revenue by Product

Product/Service	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Sep 22	Jun 22	Mar 22	Sep 21	Jun 21	Mar 21	Jun 19	Mar 19	Dec 18
Medical Products And Therapies	$1.39B	$1.33B	$1.32B	$1.26B	$569.00M	$272.00M	$263.00M	-	-	-	-	-	-	-	-	-	-	-	-	-
Healthcare Systems and Technologies	$827.00M	$773.00M	$767.00M	$704.00M	$576.00M	$296.00M	$265.00M	-	-	-	-	-	-	-	-	-	-	-	-	-
Pharmaceuticals	$668.00M	$632.00M	$612.00M	$581.00M	$578.00M	$1.67B	$580.00M	$540.00M	-	-	-	-	-	-	-	-	-	-	-	-
Kidney Care	-	-	-	-	-	-	$214.00M	-	-	-	-	-	-	-	-	-	-	-	-	-
Hillrom	-	-	-	-	-	-	-	-	-	$743.00M	$731.00M	$735.00M	$715.00M	$755.00M	-	-	-	-	-	-
E M E A Segment	-	-	-	-	-	-	-	-	-	$762.00M	$714.00M	$692.00M	$738.00M	$699.00M	$779.00M	$783.00M	$738.00M	-	-	-
E M E A	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$744.00M	$705.00M	-
Renal	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$953.00M
Other Product Or Services	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$122.00M
Medication Delivery	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$660.00M
Clinical Nutrition	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$215.00M
Advanced Surgery	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$214.00M
Acute Theapies	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$137.00M

Baxter's latest quarterly revenue breakdown by segment (product or service), as of Dec 25: Medical Products And Therapies (48.14%), Healthcare Systems and Technologies (28.69%), and Pharmaceuticals (23.17%).

Baxter Revenue Breakdown by Country

Annual Revenue by Country

Country	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
EMEA	$1.39B	$1.35B	$3.32B	$3.71B	$3.55B
Western Europe, Canada, Japan, Australia and New Zealand	$3.73B	$3.44B	$4.49B	-	-
UNITED STATES	$6.12B	$5.85B	$7.00B	-	-
Non-US	-	-	$7.81B	-	-
Latin America And Canada	-	-	-	$1.43B	$1.25B
Asia Pacific	-	-	-	$2.75B	$2.80B

Baxter's latest annual revenue breakdown by geography, as of Dec 25: UNITED STATES (54.45%), Western Europe, Canada, Japan, Australia and New Zealand (33.16%), and EMEA (12.40%).

Quarterly Revenue by Country

Country	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20
Western Europe, Canada, Japan, Australia and New Zealand	$1.02B	$936.00M	$930.00M	$838.00M	$1.43B	$852.00M	$1.16B	-	-	-	-	-	-	-	-	-	-	-	-	-
UNITED STATES	$1.55B	$1.54B	$1.54B	$1.49B	$2.69B	$1.50B	$1.66B	$5.16B	$1.77B	$35.00M	$38.00M	$34.00M	$38.00M	$36.00M	$37.00M	$203.00M	$222.00M	$217.00M	$216.00M	$1.29B
EMEA	$398.00M	$355.00M	$344.00M	$297.00M	$225.00M	$347.00M	$778.00M	-	-	-	-	-	-	-	-	-	-	-	-	-
Non-US	-	-	-	-	-	-	$1.93B	$5.79B	$1.94B	$42.00M	$43.00M	$47.00M	$38.00M	$33.00M	$41.00M	$401.00M	$759.00M	$747.00M	$706.00M	-

Baxter's latest quarterly revenue breakdown by geography, as of Dec 25: UNITED STATES (52.19%), Western Europe, Canada, Japan, Australia and New Zealand (34.43%), and EMEA (13.38%).

Baxter Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
DVA	DaVita	$13.64B	$3.42B
ATR	AptarGroup	$3.78B	$961.13M
BIO	Bio-Rad Laboratories	$2.58B	$653.00M
HIMS	Hims & Hers Health	$2.35B	$598.98M
QGEN	Qiagen	$1.97B	$458.80M
MASI	Masimo	$1.53B	$371.50M
MDGL	Madrigal Pharmaceuticals	$958.40M	$287.27M
RGEN	Repligen	$738.26M	$188.81M
BAX	Baxter	$352.00M	$2.83B
RNA	Avidity Biosciences	$18.75M	$12.47M
AVTR	Avantor	-	-

BAX Revenue FAQ

What is Baxter’s yearly revenue?

Baxter's yearly revenue for 2025 was $352M, representing a decrease of -96.69% compared to 2024. The company's yearly revenue for 2024 was $10.64B, representing an increase of 2.66% compared to 2023. BAX's yearly revenue for 2023 was $10.36B, representing an increase of 3.01% compared to 2022.

What is Baxter’s quarterly revenue?

Baxter's quarterly revenue for Q3 2025 was $2.84B, a 0.89% increase from the previous quarter (Q2 2025), and a 5.04% increase year-over-year (Q3 2024). The company's quarterly revenue for Q2 2025 was $2.81B, a 7.05% increase from the previous quarter (Q1 2025), and a 4.31% increase year-over-year (Q2 2024). BAX's quarterly revenue for Q1 2025 was $2.62B, a -4.65% decrease from the previous quarter (Q4 2024), and a 5.42% increase year-over-year (Q1 2024).

What is Baxter’s revenue growth rate?

Baxter's revenue growth rate for the last 3 years (2023-2025) was -96.60%, and for the last 5 years (2021-2025) was -97.10%.

What are Baxter’s revenue streams?

Baxter's revenue streams in c 25 are Medical Products And Therapies, Healthcare Systems and Technologies, and Pharmaceuticals. Medical Products And Therapies generated $5.3B in revenue, accounting 48.78% of the company's total revenue, up 1.77% year-over-year. Healthcare Systems and Technologies generated $3.07B in revenue, accounting 28.27% of the company's total revenue, up 4.07% year-over-year. Pharmaceuticals generated $2.49B in revenue, accounting 22.95% of the company's total revenue, up 3.40% year-over-year.

What is Baxter’s main source of revenue?

For the fiscal year ending Dec 25, the largest source of revenue of Baxter was Medical Products And Therapies. This segment made a revenue of $5.3B, representing 48.78% of the company's total revenue.